Eikon Therapeutics, Inc. Common Stock (EIKN) — Analyst estimates
Consensus analyst estimates for Eikon Therapeutics, Inc. Common Stock — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 0 | -1.72 | 1 |
| 2027 | 0 | -1.66 | 1 |
| 2028 | 0 | -5.82 | 3 |
| 2029 | 50.13M | -5.25 | 1 |
| 2030 | 134.5M | -4.29 | 1 |
Consensus analyst estimates by fiscal year.